Zymeworks (NASDAQ: ZYME) revenue
Zymeworks reported revenue of $106.0m for fiscal 2025, 38.9% more than in fiscal 2024 ($76.3m). Since fiscal 2021 its revenue has grown by 297.2%, an average growth of 41.2% a year.
Zymeworks has grown its revenue for 2 years in a row, and its best year of the last 5 was fiscal 2022. The biggest drop was in fiscal 2023, −81.6%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $106.0m | +38.9% | −$92.5m | −87.3% |
| 2024 | $76.3m | +0.4% | −$137.1m | −179.7% |
| 2023 | $76.0m | −81.6% | −$138.1m | −181.6% |
| 2022 | $412.5m | +1,446.0% | $130.5m | 31.6% |
| 2021 | $26.7m | — | −$215.6m | −808.2% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Zymeworks revenue compared with its sector
By revenue for its latest fiscal year, Zymeworks ranks 283rd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Zymeworks, 38.9%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 281st | Century Therapeutics | $109.2m | 1,556.8% |
| 282nd | Zevra Therapeutics | $106.5m | 350.9% |
| 283rd | Zymeworks | $106.0m | 38.9% |
| 284th | Sanara Medtech | $103.1m | 19.0% |
| 285th | Sutro Biopharma | $102.5m | 65.2% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Zymeworks
- How much revenue did Zymeworks make in fiscal 2025?
- Zymeworks reported revenue of $106.0m for fiscal 2025, compared with $76.3m in fiscal 2024.
- How much has the revenue of Zymeworks grown?
- Between fiscal 2021 and fiscal 2025 it went from $26.7m to $106.0m: 297.2% more, an average growth of 41.2% a year.
- What was the best year for revenue at Zymeworks?
- Of its last 5 fiscal years, fiscal 2022, with $412.5m.
- Where does Zymeworks rank in its sector by revenue?
- It ranks 283rd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Zymeworks come from?
- From the annual report (Form 10-K) that Zymeworks files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Zymeworks files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021. More on Zymeworks: the Zymeworks page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.